328 related articles for article (PubMed ID: 7794249)
1. Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin.
Miyake Y; Kozutsumi Y; Nakamura S; Fujita T; Kawasaki T
Biochem Biophys Res Commun; 1995 Jun; 211(2):396-403. PubMed ID: 7794249
[TBL] [Abstract][Full Text] [Related]
2. Dual roles of sphingolipids in signaling of the escape from and onset of apoptosis in a mouse cytotoxic T-cell line, CTLL-2.
Nakamura S; Kozutsumi Y; Sun Y; Miyake Y; Fujita T; Kawasaki T
J Biol Chem; 1996 Jan; 271(3):1255-7. PubMed ID: 8576106
[TBL] [Abstract][Full Text] [Related]
3. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations.
Johnson VJ; He Q; Osuchowski MF; Sharma RP
Toxicology; 2004 Sep; 201(1-3):67-75. PubMed ID: 15297021
[TBL] [Abstract][Full Text] [Related]
4. Fungal metabolite sulfamisterin suppresses sphingolipid synthesis through inhibition of serine palmitoyltransferase.
Yamaji-Hasegawa A; Takahashi A; Tetsuka Y; Senoh Y; Kobayashi T
Biochemistry; 2005 Jan; 44(1):268-77. PubMed ID: 15628868
[TBL] [Abstract][Full Text] [Related]
5. The identification of myriocin-binding proteins.
Chen JK; Lane WS; Schreiber SL
Chem Biol; 1999 Apr; 6(4):221-35. PubMed ID: 10099133
[TBL] [Abstract][Full Text] [Related]
6. A novel role for sphingolipid intermediates in activation-induced cell death in T cells.
Solomon JC; Sharma K; Wei LX; Fujita T; Shi YF
Cell Death Differ; 2003 Feb; 10(2):193-202. PubMed ID: 12700647
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice.
Park TS; Panek RL; Mueller SB; Hanselman JC; Rosebury WS; Robertson AW; Kindt EK; Homan R; Karathanasis SK; Rekhter MD
Circulation; 2004 Nov; 110(22):3465-71. PubMed ID: 15545514
[TBL] [Abstract][Full Text] [Related]
8. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis of CTLL-2 cells induced by an immunosuppressant, ISP-I, is caspase-3-like protease-independent.
Yamaji T; Nakamura S; Takematsu H; Kawasaki T; Kozutsumi Y
J Biochem; 2001 Apr; 129(4):521-7. PubMed ID: 11275550
[TBL] [Abstract][Full Text] [Related]
10. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
[TBL] [Abstract][Full Text] [Related]
11. Sli2 (Ypk1), a homologue of mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-mediated signaling pathway of yeast.
Sun Y; Taniguchi R; Tanoue D; Yamaji T; Takematsu H; Mori K; Fujita T; Kawasaki T; Kozutsumi Y
Mol Cell Biol; 2000 Jun; 20(12):4411-9. PubMed ID: 10825204
[TBL] [Abstract][Full Text] [Related]
12. Myriocin, a serine palmitoyltransferase inhibitor, blocks cytokinesis in Leishmania (Viannia) braziliensis promastigotes.
Castro EV; Yoneyama KG; Haapalainen EF; Toledo MS; Takahashi HK; Straus AH
J Eukaryot Microbiol; 2013; 60(4):377-87. PubMed ID: 23659342
[TBL] [Abstract][Full Text] [Related]
13. [Action mechanism of immunosuppressant, ISP-1].
Yamaji T; Sun Y; Kozutsumi Y
Tanpakushitsu Kakusan Koso; 1998 Dec; 43(16 Suppl):2503-9. PubMed ID: 9883679
[No Abstract] [Full Text] [Related]
14. Entamoeba invadens: sphingolipids metabolic regulation is the main component of a PKC signaling pathway in controlling cell growth and proliferation.
Cerbon J; Olguin T; Alvarez-Grave PR; López-Sánchez RC
Exp Parasitol; 2009 Jun; 122(2):106-11. PubMed ID: 19249300
[TBL] [Abstract][Full Text] [Related]
15. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
[TBL] [Abstract][Full Text] [Related]
16. Specificity of inhibitors of serine palmitoyltransferase (SPT), a key enzyme in sphingolipid biosynthesis, in intact cells. A novel evaluation system using an SPT-defective mammalian cell mutant.
Hanada K; Nishijima M; Fujita T; Kobayashi S
Biochem Pharmacol; 2000 May; 59(10):1211-6. PubMed ID: 10736421
[TBL] [Abstract][Full Text] [Related]
17. The essential structures of ISP-I that influence serine palmitoyltransferase inhibition in Chinese hamster ovary cells.
Mizukoshi K; Matsumoto K; Hirose R; Fujita T
Biol Pharm Bull; 2012; 35(8):1349-53. PubMed ID: 22863936
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration.
Glaros EN; Kim WS; Wu BJ; Suarna C; Quinn CM; Rye KA; Stocker R; Jessup W; Garner B
Biochem Pharmacol; 2007 May; 73(9):1340-6. PubMed ID: 17239824
[TBL] [Abstract][Full Text] [Related]
19. Host sphingolipid biosynthesis is a promising therapeutic target for the inhibition of hepatitis B virus replication.
Tatematsu K; Tanaka Y; Sugiyama M; Sudoh M; Mizokami M
J Med Virol; 2011 Apr; 83(4):587-93. PubMed ID: 21328371
[TBL] [Abstract][Full Text] [Related]
20. A role for the de novo sphingolipids in apoptosis of photosensitized cells.
Wispriyono B; Schmelz E; Pelayo H; Hanada K; Separovic D
Exp Cell Res; 2002 Sep; 279(1):153-65. PubMed ID: 12213223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
